Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) EBT (2020 - 2025)

Agilon Health (AGL) has disclosed EBT for 6 consecutive years, with -$187.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 79.18% year-over-year to -$187.6 million, compared with a TTM value of -$404.1 million through Dec 2025, down 62.4%, and an annual FY2025 reading of -$404.1 million, down 62.4% over the prior year.
  • EBT was -$187.6 million for Q4 2025 at Agilon Health, down from -$110.5 million in the prior quarter.
  • Across five years, EBT topped out at $8.2 million in Q1 2023 and bottomed at -$296.9 million in Q2 2021.
  • Average EBT over 5 years is -$66.5 million, with a median of -$32.9 million recorded in 2021.
  • The sharpest move saw EBT plummeted 8616.79% in 2021, then surged 1150.69% in 2023.
  • Year by year, EBT stood at -$35.6 million in 2021, then fell by 14.87% to -$40.9 million in 2022, then plummeted by 307.77% to -$166.9 million in 2023, then surged by 37.27% to -$104.7 million in 2024, then tumbled by 79.18% to -$187.6 million in 2025.
  • Business Quant data shows EBT for AGL at -$187.6 million in Q4 2025, -$110.5 million in Q3 2025, and -$104.3 million in Q2 2025.